Tyagarajan Seshu 4
4 · Candel Therapeutics, Inc. · Filed Apr 15, 2022
Insider Transaction Report
Form 4
Tyagarajan Seshu
Chief Technology Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-04-14+120,000→ 120,000 totalExercise: $5.19Exp: 2032-04-14→ Common Stock (120,000 underlying)
Footnotes (1)
- [F1]25% of the shares underlying this option shall vest and become exercisable on April 14, 2023, with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.